Thursday, April 03, 2025
Researchers identify “master regulator” gene that could lead to more effective treatment for patients with ovarian cancer
In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.
Wednesday, April 02, 2025
Researchers Reveal Key Brain Differences to Explain Why Ritalin Helps Improve Focus in Some More Than Others
Nearly 16 million American adults have been diagnosed with attention deficit hyperactivity disorder (ADHD), but evidence suggests that more than 30 percent of them don’t respond well to stimulant medications like Ritalin and Adderall. A new clinical trial provides a surprising explanation for why this may be the case: There are individual differences in how our brains circuits are wired, including the chemical circuits responsible for memory and concentration, according to a new study co-led by the University of Maryland School of Medicine (UMSOM) and performed at the National Institutes of Health (NIH) Clinical Center.
Tuesday, March 25, 2025
Internationally Recognized Vaccine Expert Dr. Paul Offit to Deliver Graduation Address to the University of Maryland School of Medicine’s 216th Graduating Class
Leading vaccine advocate Paul Offit, MD, an internationally recognized immunologist and virologist, will deliver the keynote address for this year’s graduating medical student class. He is best known as co-inventor of the rotavirus vaccine, RotaTeq, which is universally recommended for infants by the CDC and has been credited for saving hundreds of lives every day.
Monday, March 24, 2025
Susan Kinter Named as New President and CEO of the Maryland Medicine Comprehensive Insurance Program
Susan Kinter, BSN, JD, stepped into her new role at MMCIP on February 24 after serving in successive executive roles at the organization since 1998. In her new role, she will guide MMCIP in its core missions to ensure physician, staff, and patient safety across all the University of Maryland system member organizations and practice groups, as well as administering the Health Professional Liability Insurance Program for physicians and nurses.
Thursday, March 13, 2025
UMSOM Rising Third-Year Medical Students Celebrate Transition to Clinical Care Training at Annual Student Clinician Ceremony
The University of Maryland School of Medicine (UMSOM) celebrated 165 rising third-year medical students at the Annual Student Clinician Ceremony on March 4, as they prepare to begin their clinical care training. Over the next two years, students will transition from the classroom to the bedside to gain experience seeing patients through a wide variety of specialties within local healthcare organizations.
Wednesday, March 12, 2025
Meningococcal Vaccine Found to be Safe and Effective for Infants in Sub-Saharan Africa
University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in young children beginning at 9 months of age. This study provided evidence that formed the basis for the World Health Organization’s (WHO) decision last year to recommend the pentavalent Men5CV meningitis vaccine for infants ages 9 months and older.
Tuesday, March 11, 2025
First ever UMSOM "Shark Tank" competition for biomedical research awards $120,000 for innovative faculty projects
The members of the University of Maryland School of Medicine (UMSOM) Board of Visitors (BOV) regularly serve as advisors to the school on strategic planning, fundraising, and philanthropy. But on December 17, the Board members took on a new role for the very first time — they became “sharks.”
Tuesday, March 04, 2025
In Memoriam: Dr. Joseph S. McLaughlin
Dr. Joseph S. McLaughlin had a distinguished and longstanding affiliation with the University of Maryland School of Medicine (UM SOM) and the University of Maryland Medical Center (UMMC) spanning 66 years. His profound impact on medical education, patient care, and surgical innovation leaves a lasting legacy at the University of Maryland.
Wednesday, February 26, 2025
Innovative CT Scan Technique Could Improve Prognosis and Treatments for Head and Neck Cancers, New Research Suggests
Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every year with one in five cases occurring in people younger than 55, according to the American Cancer Society. A new study provides insights that may eventually help oncologists better predict how the disease will respond to certain therapies, leading to improved survival outcomes for patients.
Friday, February 21, 2025
UM School of Medicine Dermatology Researchers Discover New Skin Disease Using Innovative Diagnostic Platform
A significant number of Americans experience chronic inflammatory skin conditions with no pinpointed cause and often no effective treatments beyond symptom management. Now a new study could pave the way for precision-medicine based diagnostic testing and targeted treatment.